Results for tag: "Amonafide"

Amonafide is a type of oncology drug used to treat certain types of cancer. It is a small molecule inhibitor of the enzyme topoisomerase II, which is involved in DNA replication and repair. Amonafide is used in combination with other drugs to treat acute myeloid leukemia (AML) and metastatic breast cancer. It is also being studied for its potential use in other types of cancer. Amonafide is a relatively new drug, and the market for it is still developing. It is currently approved in the United States and Europe, and is being studied in clinical trials in other countries. The drug is available in both oral and intravenous formulations. The market for Amonafide is highly competitive, with several companies developing and marketing the drug. These include Merck, Pfizer, Novartis, and AstraZeneca. Other companies, such as Celgene and GlaxoSmithKline, are also involved in the development and marketing of Amonafide. Show Less Read more